LOGO
LOGO

Viking Therapeutics, Inc. (VKTX)

  • Viking Therapeutics Appoints Hubert C. Chen As Chief Medical Officer 6/11/2026 7:12:52 AM
  • Viking Therapeutics Presents Data From 13-Week Phase 2 VENTURE-Oral Dosing Trial Of VK2735 At ECO 2026 5/12/2026 8:13:39 AM
  • Viking Therapeutics Announces Completion Of Enrollment In Phase 3 VANQUISH-2 Trial Of VK2735 3/26/2026 7:07:23 AM
  • Older Articles